Dados B3 › YBRA4 × SCAR3
YBRA4 × SCAR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | YBRA4 | SCAR3 | year |
|---|---|---|---|
| ROE | 0.0%! | 4.9% | 2025 |
| ROIC | -0.0%! | 2.6%! | 2025 |
| ROA | -0.0%! | -1.6% | 2025 |
| Gross margin | 100.0%! | 49.4% | 2023 |
| EBIT margin | 79.3%! | 39.4% | 2023 |
| Net margin | 71.3%! | 21.7% | 2023 |
| Net debt/EBITDA | — | 3.23x | no year where both have it |
| Current ratio | 0.01x! | 1.78x | 2025 |
| Revenue growth (1y) | — | -41.1% | no year where both have it |
| Revenue growth (5y CAGR) | — | -2.6% | no year where both have it |
| Piotroski F-Score | 0/9! | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | YBRA4 | SCAR3 | year |
|---|---|---|---|
| P/E | — | 12.57x | None × 2025 |
| P/B | — | 0.76x | None × 2025 |
| EV/EBITDA | — | 9.39x | None × 2025 |
| FCF yield | — | -21.2% | None × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.